168 related articles for article (PubMed ID: 8862015)
41. Malignant fibrous histiocytoma phenotype in pleomorphic sarcoma differentiation in recurrent disease.
Costa MJ
Arch Pathol Lab Med; 1994 Feb; 118(2):160-4. PubMed ID: 8311656
[TBL] [Abstract][Full Text] [Related]
42. Multidrug resistance-associated protein (MRP) in haematological malignancies.
Nooter K; Burger H; Stoter G
Leuk Lymphoma; 1996 Feb; 20(5-6):381-7. PubMed ID: 8833393
[TBL] [Abstract][Full Text] [Related]
43. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas.
Wadayama B; Toguchida J; Yamaguchi T; Sasaki MS; Yamamuro T
Br J Cancer; 1993 Dec; 68(6):1134-9. PubMed ID: 8260365
[TBL] [Abstract][Full Text] [Related]
44. [Angiotensin II-induced hypertension chemotherapy of bone and soft-tissue sarcomas].
Tsuchiya H; Tomita K; Sugihara M; Shimizu H; Yasutake H; Morishita H; Morikawa S; Ohno M; Bunko H; Seto M
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1776-81. PubMed ID: 2543322
[TBL] [Abstract][Full Text] [Related]
45. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
46. [The pathology of soft tissue sarcomas].
Schmidt D
Radiologe; 1992 Dec; 32(12):579-83. PubMed ID: 1492148
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood.
Chan HS; Thorner PS; Haddad G; Ling V
J Clin Oncol; 1990 Apr; 8(4):689-704. PubMed ID: 1968964
[TBL] [Abstract][Full Text] [Related]
48. Analysis of multiple sarcoma expression datasets: implications for classification, oncogenic pathway activation and chemotherapy resistance.
Konstantinopoulos PA; Fountzilas E; Goldsmith JD; Bhasin M; Pillay K; Francoeur N; Libermann TA; Gebhardt MC; Spentzos D
PLoS One; 2010 Apr; 5(4):e9747. PubMed ID: 20368975
[TBL] [Abstract][Full Text] [Related]
49. Genetic predictors for drug resistance in soft tissue sarcoma: a review of publications in 2004.
Fayette J; Blay JY
Curr Opin Oncol; 2005 Jul; 17(4):370-5. PubMed ID: 15933471
[TBL] [Abstract][Full Text] [Related]
50. Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.
Bramwell VH; Morris D; Ernst DS; Hings I; Blackstein M; Venner PM; Ette EI; Harding MW; Waxman A; Demetri GD
Clin Cancer Res; 2002 Feb; 8(2):383-93. PubMed ID: 11839653
[TBL] [Abstract][Full Text] [Related]
51. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
[TBL] [Abstract][Full Text] [Related]
52. Multidrug resistance and malignancy in human osteosarcoma.
Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
[TBL] [Abstract][Full Text] [Related]
53. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.
Frustaci S; Gherlinzoni F; De Paoli A; Bonetti M; Azzarelli A; Comandone A; Olmi P; Buonadonna A; Pignatti G; Barbieri E; Apice G; Zmerly H; Serraino D; Picci P
J Clin Oncol; 2001 Mar; 19(5):1238-47. PubMed ID: 11230464
[TBL] [Abstract][Full Text] [Related]
54. [Chemotherapy for pulmonary metastases of soft tissue sarcoma].
Kito M; Umeda T
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1701-6. PubMed ID: 9757195
[TBL] [Abstract][Full Text] [Related]
55. Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells.
Moiseeva NI; Laletina LA; Fetisov TI; Makhmudova LF; Manikaylo AE; Fomina LY; Burov DA; Lesovaya EA; Bokhyan BY; Zinovieva VY; Vilkova AS; Mekheda LV; Kozlov NA; Scherbakov AM; Kirilin EM; Belitsky GA; Yakubovskaya MG; Kirsanov KI
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328603
[TBL] [Abstract][Full Text] [Related]
56. Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.
Trock BJ; Leonessa F; Clarke R
J Natl Cancer Inst; 1997 Jul; 89(13):917-31. PubMed ID: 9214671
[TBL] [Abstract][Full Text] [Related]
57. Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas.
Hoffmann J; Schmidt-Peter P; Hänsch W; Naundorf H; Bunge A; Becker M; Fichtner I
Clin Cancer Res; 1999 Aug; 5(8):2198-204. PubMed ID: 10473106
[TBL] [Abstract][Full Text] [Related]
58. Multidrug resistance in breast cancer--is the jury in yet?
Kaye SB
J Natl Cancer Inst; 1997 Jul; 89(13):902-3. PubMed ID: 9214663
[No Abstract] [Full Text] [Related]
59. Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets.
Kim J; Kim JH; Kang HG; Park SY; Yu JY; Lee EY; Oh SE; Kim YH; Yun T; Park C; Cho SY; You HJ
BMC Med Genet; 2018 Dec; 19(Suppl 1):216. PubMed ID: 30598078
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of the drug resistance-associated protein metallothionein does not correlate with response of sarcomas to isolated limb perfusion treatment.
Grabellus F; Sheu SY; Tötsch M; Lehmann N; Kaiser GM; Jasani B; Taeger G; Schmid KW
J Surg Oncol; 2010 May; 101(6):465-70. PubMed ID: 20401916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
